My ISA Watch List: GlaxoSmithKline plc, Diageo plc And PZ Cussons plc

Why I’m watching GaxoSmithKline plc (LON: GSK), Diageo plc (LON: DGE) and PZ Cussons plc (LON: PZC) for this year’s ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

From 6 April 2016, we get another ISA allowance of £15,240, and that’s a tax-free investment opportunity worth grabbing.

Leading with quality

I’m looking for firms that can pay a reliable and growing stream of dividends in the years to come. If the company has a quality business with strong cash flow, capital growth should follow. Expanding dividend payments and a rising share price mean a double win that should drive pleasing total returns.

Quality firms can go on my watch list waiting for a sensible entry point, such as during periods of general market weakness, or when a temporary issue knocks the firm’s share price.

Today’s focus is on GlaxoSmithKline (LSE: GSK), Diageo (LSE: DGE) and PZ Cussons (LSE: PZC). 

Defensive attributes

These firms attract because of their defensive qualities. GlaxoSmithKline, the pharmaceutical giant, trades in an industry characterised by consistent demand, and people often repeat-purchase the firm’s products. That set-up tends to generate reliable flows of cash for GlaxoSmithKline. Meanwhile, Diageo’s alcoholic drinks output also feeds into a consumer-driven market. People come back repeatedly for their favourite tipple and that translates into a reliable cash stream for Diageo.

PZ Cusson’s portfolio of consumable goods brands in the personal care, home care, beauty, food and nutrition markets is also a great cash generator. The common theme linking these three firms is that they all sell stuff that people need over and over again, profitably.

Outlooks

In February, GlaxoSmithKline’s chief executive said: “For 2016, we continue to expect core EPS percentage growth to reach double-digits on a constant currency basis, although we are also mindful that the macroeconomic and healthcare environment will continue to be challenging.”

Despite possible headwinds, GlaxoSmithKline looks set to lumber through 2016 and beyond. The firm announced a special dividend for 2015 and that strikes me as a good indicator that the firm remains in good health.

In January, Diageo’s chief executive said: “While trading conditions remain challenging in some markets, Diageo’s brands, capabilities in marketing and innovation and our route to consumer have proved resilient. I am confident that Diageo can deliver improved, sustained performance.”

Diageo’s top man is confident that the drinks provider can keep powering forward and so am I. The firm operates in an attractive industry and enjoys substantial economic moats with its popular brands.

Commenting on the firm’s interim results in January, PZ Cussons’ chairman said: These are a steady set of results in what have been challenging markets with overall revenue and profitability broadly flat versus the comparative period. We remain confident about the medium and long-term opportunities which should begin to materialise.”

I’m also confident that PZ Cussons’ business model will keep it afloat and steady in difficult times, and growing nicely in the good times.

All three of these firms operate good quality, cash-generating and enduring businesses, and because of that, their valuations tend to look a little pricey at times. However, buying on dips, down days and during times of general market malaise can be one way of building up a position in the longer-term growth stories on offer. That’s why I think they’re good candidates for my ISA watch list.

Kevin Godbold has no position in any shares mentioned. The Motley Fool UK owns shares of PZ Cussons. The Motley Fool UK has recommended Diageo and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Want a £1m Stocks and Shares ISA? Step 1 starts before 5 April

Dr James Fox explains why the Stocks and Shares ISA is an incredible vehicle, and why investors may want to…

Read more »

Happy woman commuting on a train and checking her mobile phone while using headphones
Investing Articles

2 dirt-cheap stocks to consider buying for an ISA portfolio in April

This pair of UK shares are down by double digits in recent months. Ben McPoland sees both as stocks to…

Read more »

Front view photo of a woman using digital tablet in London
Growth Shares

I think this undervalued penny stock has serious potential to outperform

Jon Smith points out a penny stock that's started to rise as the company pushes ahead with a transformation that…

Read more »

Close-up of children holding a planet at the beach
Investing Articles

2 dividend-paying investment trusts to consider for a Stocks and Shares ISA

These two London-listed funds source their dividends globally, offering income investors diversification inside an ISA portfolio.

Read more »

Businesswoman calculating finances in an office
Investing Articles

Waiting for a stock market crash? This FTSE 100 superstar just fell 19% in a day

A stock market crash can be a great time to buy shares. But one of the FTSE 100’s leading lights…

Read more »

Road trip. Father and son travelling together by car
Investing Articles

Rolls-Royce shares down 19%. Why is this major broker still as bullish as ever?

Our writer looks into the long-term investment case for Rolls-Royce shares after a 19% dip, and finds at least one…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

9% yield! But a cut’s coming for 1 of the UK’s most reliable dividend stocks

While other housebuilding stocks have had big dividend cuts in recent years, Taylor Wimpey's been incredibly resilient. But that's set…

Read more »

Bearded man writing on notepad in front of computer
Investing Articles

Stock market crash? 1 Nasdaq share I’m keeping an eye on

With the stock market taking the elevator down recently, out writer has his eye on a company hoping to compete…

Read more »